Dose trends for second-generation antipsychotic treatment of schizophrenia and bipolar disorder.

Citrome, Leslie; Reist, Christopher; Palmer, Liisa; Montejano, Leslie; Lenhart, Greg; Cuffel, Brian; Harnett, James; Sanders, Kafi N

Citrome, Leslie; Reist, Christopher; Palmer, Liisa; Montejano, Leslie; Lenhart, Greg; Cuffel, Brian; Harnett, James; Sanders, Kafi N.

Affiliation

Citrome L; Nathan S. Kline Institute for Psychiatric Research, 140 Old Orangeburg Road, Orangeburg, NY 10962, USA. citrome@nki.rfmh.org

Schizophr Res ; 108(1-3): 238-44, 2009 Mar.

Article in En | MEDLINE | ID: mdl-19106035

Subject(s)

Antidepressive Agents, Second-Generation/therapeutic use; Bipolar Disorder/drug therapy; Schizophrenia/drug therapy; Adult; Cohort Studies; Databases, Bibliographic/statistics & numerical data; Dose-Response Relationship, Drug; Humans; Psychiatric Status Rating Scales; Retrospective Studies; Time Factors; Treatment Outcome; Young Adult

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google

Full text: 1 Database: MEDLINE Main subject: Schizophrenia / Bipolar Disorder / Antidepressive Agents, Second-Generation Type of study: Etiology_studies / Evaluation_studies / Incidence_studies / Observational_studies / Prognostic_studies / Risk_factors_studies Limits: Adult / Humans Language: En Journal: Schizophr Res Journal subject: PSIQUIATRIA Year: 2009 Type: Article Affiliation country: United States

Fulltext

Add to My VHL

XML

PubMed Links

Search on Google